Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Dietlein

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Biology|April 13, 2012
Cellular response on Auger- and Beta-emitting nuclides: human embryonic stem cells (hESC) vs. keratinocytesThomas Fischer, Ferdinand Sudbrock, Ekkehard Pomplun, et al.
BMC Cancer|June 18, 2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trialLutz van Heek, Colin Stuka, Helen Kaul, et al.
British Journal of Haematology|December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphomaStefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
Nuclear Medicine Communications|January 13, 2006
Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID miceChristina Otto, Markus Jensen, Markus Dietlein, et al.
Frontiers in Oncology|October 31, 2022
Case report: Use of <sup>68</sup>Ga-DOTATATE-PET for treatment guidance in complex meningioma diseaseAnna-Katharina Meißner, Niklas von Spreckelsen, Abdulkader Al Shughri, et al.
Nuklearmedizin. Nuclear Medicine|March 17, 2022
Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Molecular Imaging and Biology|May 28, 2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate CancerMarkus Dietlein, Carsten Kobe, Georg Kuhnert, et al.
EJNMMI Research|July 27, 2019
Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancerMelanie Hohberg, Carsten Kobe, Philipp Krapf, et al.
Nuklearmedizin. Nuclear Medicine|April 27, 2022
Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Neuroimage. Clinical|August 19, 2019
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to ADNils Richter, Nils Nellessen, Julian Dronse, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Biology|April 13, 2012
Cellular response on Auger- and Beta-emitting nuclides: human embryonic stem cells (hESC) vs. keratinocytesThomas Fischer, Ferdinand Sudbrock, Ekkehard Pomplun, et al.
BMC Cancer|June 18, 2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trialLutz van Heek, Colin Stuka, Helen Kaul, et al.
British Journal of Haematology|December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphomaStefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
Nuclear Medicine Communications|January 13, 2006
Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID miceChristina Otto, Markus Jensen, Markus Dietlein, et al.
Frontiers in Oncology|October 31, 2022
Case report: Use of <sup>68</sup>Ga-DOTATATE-PET for treatment guidance in complex meningioma diseaseAnna-Katharina Meißner, Niklas von Spreckelsen, Abdulkader Al Shughri, et al.
Nuklearmedizin. Nuclear Medicine|March 17, 2022
Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Molecular Imaging and Biology|May 28, 2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate CancerMarkus Dietlein, Carsten Kobe, Georg Kuhnert, et al.
EJNMMI Research|July 27, 2019
Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancerMelanie Hohberg, Carsten Kobe, Philipp Krapf, et al.
Nuklearmedizin. Nuclear Medicine|April 27, 2022
Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Neuroimage. Clinical|August 19, 2019
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to ADNils Richter, Nils Nellessen, Julian Dronse, et al.
Pageof 15